Download PDF
Z Gastroenterol 2012; 50(6): 595-600
DOI: 10.1055/s-0031-1299462
Übersicht
© Georg Thieme Verlag KG Stuttgart · New York

Postoperative Komplikationen nach Darmresektionen bei Patienten mit Morbus Crohn: Risiko, Behandlung, Prävention

Postoperative Morbidity after Bowel Resections in Patients with Crohn’s Disease: Risk, Management Strategies, Prevention
I. Iesalnieks
1   Abteilung für Allgemein- und Viszeralchirurgie, Marienhospital Gelsenkirchen
2   Klinik und Poliklinik für Chirurgie, Universitätsklinikum Regensburg
,
F. Dederichs
3   Abteilung für Innere Medizin und Gastroenterologie, Marienhospital Gelsenkirchen
,
A. Kilger
4   Institut für Anästhesie und Intensivmedizin, Klinikum Deggendorf
,
H. J. Schlitt
2   Klinik und Poliklinik für Chirurgie, Universitätsklinikum Regensburg
,
A. Agha
2   Klinik und Poliklinik für Chirurgie, Universitätsklinikum Regensburg
› Author Affiliations
Further Information

Publication History

26 September 2011

13 March 2012

Publication Date:
01 June 2012 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Darmresektionen bei Patienten mit Morbus Crohn gehen mit einer erhöhten postoperativen Morbidität einher. Die Häufigkeit von postoperativen intraabdominellen septischen Komplikationen (Anastomoseninsuffizienz, intraabdominelle Abszesse, Darmfisteln, Peritonitis) liegt bei 5 – 30 %, wobei v. a. der präoperative Gewichtsverlust, langfristig bestehende therapierefraktäre Beschwerden sowie Vorliegen eines perforierenden Krankheitsphänotyps das Komplikationsrisiko erhöhen. Durch eine präoperative Ernährungstherapie, perkutane Abszessdrainagen, Absetzen der Steroide und prophylaktische Antibiotikagaben kann das postoperative Risiko möglicherweise reduziert werden, allerdings ist die Datenlage noch nicht ausreichend. Immunsuppressiva, insbesondere Azathioprin, müssen vor einer Darmresektion nicht abgesetzt werden. Postoperative intraabdominelle septische Komplikationen sind bei Patienten mit terminaler Ileitis langfristig mit weiteren Krankheitskomplikationen und Darmresektionen assoziiert. Die Prognose kann jedoch bei diesen Patienten verbessert werden, wenn die aufgetretenen Komplikationen mittels Schaffung einer Diskontinuitätssituation behandelt werden. Bei Patienten mit Crohn-Colitis führt die postoperative Morbidität nicht zwangsläufig zur Verschlechterung der Gesamtprognose.

Abstract

The postoperative morbidity rate following bowel resections for Crohn’s disease is higher than for other benign disease. The incidence of postoperative intraabdominal septic complications (anastomotic leak, bowel fistula, intraabdominal abscess, peritonitis) is 5 – 30 %. Preoperative weight loss, prolonged refractory symptoms and penetrating disease behaviour are significant determinants of postoperative complication risk. Preoperative enteral nutrition, antibiotics, percutaneous abscess drainage and cessation of steroids might reduce the risk of surgery, however, more evidence is needed. The intake of immunosuppressive agents (mainly, azathioprine) can be continued perioperatively. The occurrence of postoperative intraabdominal septic complications is associated with an increased risk of surgical recurrence in patients with terminal ileitis, however, the long-term prognosis could be improved in the latter patients by secondary fecal diversion. There is no association between postoperative morbidity and long-term outcome in patients with Crohn’s colitis.

Schlüsselwörter

Morbus Crohn - Chirurgie - Outcome

Key words

Crohn’s disease - surgery - outcome
 

  • Literatur

  • 1 Olaison G, Sjödahl R, Tagesson C. Glucocorticoid treatment in ileal Crohn’s disease: relief of symptoms but not of endoscopically viewed inflammation. Gut 1990; 31: 325-328
    CrossrefPubMedGoogle Scholar
  • 2 Lazarev M, Ullman T, Schraut WH et al. Small bowel resection rates in Crohn’s disease and the indication for surgery over time: experience from a large tertiary care center. Inflamm Bowel Dis 2010; 16: 830-835
    CrossrefPubMedGoogle Scholar
  • 3 Jones DW, Finlayson SR. Trends in surgery for Crohn’s disease in the era of infliximab. Ann Surg 2010; 252: 307-312
    CrossrefPubMedGoogle Scholar
  • 4 Peyrin-Biroulet L, Oussalah A, Williet N et al. Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn’s disease. Gut 2011; 60: 930-936
    CrossrefPubMedGoogle Scholar
  • 5 Penner RM, Madsen KL, Fedorak RN. Postoperative Crohn’s disease. Inflamm Bowel Dis 2005; 11: 765-777
    CrossrefPubMedGoogle Scholar
  • 6 Peyrin-Biroulet L, Deltenre P, Ardizzone S et al. Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn’s disease: a meta-analysis. Am J Gastroenterol 2009; 104: 2089-2096
    CrossrefPubMedGoogle Scholar
  • 7 Regueiro M, Schraut W, Baidoo L et al. Infliximab prevents Crohn’s disease recurrence after ileal resection. Gastroenterology 2009; 136: 441-450
    CrossrefPubMedGoogle Scholar
  • 8 Savarino E, Dulbecco P, Bodini G et al. Prevention of postoperative recurrence of Crohn’s disease by Adalimumab: a case series. Eur J Gastroenterol Hepatol 22.12.2011; [Epub ahead of print]
    PubMedGoogle Scholar
  • 9 Economou M, Pappas G. New global map of Crohn’s disease: Genetic, environmental, and socioeconomic correlations. Inflamm Bowel Dis 2008; 14: 709-720
    CrossrefPubMedGoogle Scholar
  • 10 Iesalnieks I, Kilger A, Glass H et al. Intraabdominal septic complications following bowel resection for Crohn’s disease: detrimental influence on long-term outcome. Int J Colorectal Dis 2008; 23: 1167-1174
    CrossrefPubMedGoogle Scholar
  • 11 Iesalnieks I, Kilger A, Glass H et al. Perforating Crohn’s ileitis: delay of surgery is associated with inferior postoperative outcome. Inflamm Bowel Dis 2010; 16: 2125-2130
    CrossrefPubMedGoogle Scholar
  • 12 Post S, Betzler M, von Ditfurth B et al. Risks of intestinal anastomoses in Crohn’s disease. Ann Surg 1991; 213: 37-42
    CrossrefPubMedGoogle Scholar
  • 13 Yamamoto T, Allan RN, Keighley MR. Risk factors for intra-abdominal sepsis after surgery in Crohn’s disease. Dis Colon Rectum 2000; 43: 1141-1145
    CrossrefPubMedGoogle Scholar
  • 14 Alves A, Panis Y, Bouhnik Y et al. Risk factors for intra-abdominal septic complications after a first ileocecal resection for Crohn’s disease: a multivariate analysis in 161 consecutive patients. Dis Colon Rectum 2007; 50: 331-336
    CrossrefPubMedGoogle Scholar
  • 15 Bruewer M, Utech M, Rijcken EJ et al. Preoperative steroid administration: effect on morbidity among patients undergoing bowel resection for Crohn’s disease. World J Surg 2003; 27: 1306-1310
    CrossrefPubMedGoogle Scholar
  • 16 Heimann TM, Greenstein AJ, Mechanic L et al. Early complications following surgical treatment for Crohn’s disease. Ann Surg 1985; 201: 494-498
    CrossrefPubMedGoogle Scholar
  • 17 Appau KA, Fazio VW, Shen B et al. Use of infliximab within 3 months of ileocolonic resection is associated with adverse postoperative outcomes in Crohn’s patients. J Gastrointest Surg 2008; 12: 1738-1744
    CrossrefPubMedGoogle Scholar
  • 18 Resegotti A, Astegiano M, Farina EC et al. Side-to-side stapled anastomosis strongly reduces anastomotic leak rates in Crohn’s disease surgery. Dis Colon Rectum 2005; 48: 464-468
    CrossrefPubMedGoogle Scholar
  • 19 Zerbib P, Koriche D, Truant S et al. Pre-operative management is associated with low rate of post-operative morbidity in penetrating Crohn’s disease. Aliment Pharmacol Ther 2010; 32: 459-465
    CrossrefPubMedGoogle Scholar
  • 20 Tay GS, Binion DG, Eastwood D et al. Multivariate analysis suggests improved perioperative outcome in Crohn’s disease patients receiving immunomodulator therapy after segmental resection and/or strictureplasty. Surgery 2003; 134: 565-572
    CrossrefPubMedGoogle Scholar
  • 21 Samimi R, Flasar MH, Kavic S et al. Outcome of medical treatment of stricturing and penetrating Crohn’s disease: a retrospective study. Inflamm Bowel Dis 2010; 16: 1187-1194
    CrossrefPubMedGoogle Scholar
  • 22 Muñoz-Juárez M, Yamamoto T, Wolff BG et al. Wide-lumen stapled anastomosis vs. conventional end-to-end anastomosis in the treatment of Crohn’s disease. Dis Colon Rectum 2001; 44: 20-25
    CrossrefPubMedGoogle Scholar
  • 23 Gasche C, Scholmerich J, Brynskov J et al. A simple classification of Crohn’s disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000; 6: 8-15
    CrossrefPubMedGoogle Scholar
  • 24 Satsangi J, Silverberg MS. The Montreal classification of inflammatory bowel disease: Controversies, consensus, and implications. Gut 2006; 55: 749-753
    CrossrefPubMedGoogle Scholar
  • 25 Louis E, Collard A. Behaviour of Crohn’s disease according to the Vienna classification: changing pattern over the course of disease. Gut 2001; 49: 777-782
    CrossrefPubMedGoogle Scholar
  • 26 Oostenbrug LE, van Dullemen HM. Clinical outcome of Crohn’s disease according to the Vienna classification: disease location is a useful predictor of disease course. Eur J Gastroenterol Hepatol 2006; 18: 255-261
    CrossrefPubMedGoogle Scholar
  • 27 Greenstein AJ, Lachman P, Sachar DB et al. Perforating and non-perforating indications for repeated operations in Crohn’s disease: evidence for two clinical forms. Gut 1988; 29: 588-592
    CrossrefPubMedGoogle Scholar
  • 28 Nasir BS, Dozois EJ, Cima RR et al. Perioperative anti-tumor necrosis factor therapy does not increase the rate of early postoperative complications in Crohn’s disease. J Gastrointest Surg 2010; 14: 1859-1865
    CrossrefPubMedGoogle Scholar
  • 29 Ozuner G, Fazio VW, Lavery IC et al. How safe is strictureplasty in the management of Crohn’s disease?. Am J Surg 1996; 171: 57-60
    CrossrefPubMedGoogle Scholar
  • 30 Dietz DW, Laureti S, Strong SA et al. Safety and longterm efficacy of strictureplasty in 314 patients with obstructing small bowel Crohn’s disease. J Am Coll Surg 2001; 192: 330-337
    CrossrefPubMedGoogle Scholar
  • 31 Fearnhead NS, Chowdhury R, Box B et al. Long-term follow-up of strictureplasty for Crohn’s disease. Br J Surg 2006; 93: 475-482
    CrossrefPubMedGoogle Scholar
  • 32 Subramanian V, Saxena S, Kang JY et al. Preoperative steroid use and risk of postoperative complications in patients with inflammatory bowel disease undergoing abdominal surgery. Am J Gastroenterol 2008; 103: 2373-2381
    CrossrefPubMedGoogle Scholar
  • 33 Colombel JF, Loftus Jr EV, Tremaine WJ et al. Early postoperative complications are not increased in patients with Crohn’s disease treated perioperatively with infliximab or immunosuppressive therapy. Am J Gastroenterol 2004; 99: 878-883
    CrossrefPubMedGoogle Scholar
  • 34 Lorenz D, Lorenz U, Hagmüller E et al. Morbus Crohn: Resektionstherapie im Verlauf von zwei Jahrzehnten. Zentralbl Chir 1993; 118: 127-133
    PubMedGoogle Scholar
  • 35 Simillis C, Purkayastha S, Yamamoto T et al. A meta-analysis comparing conventional end-to-end anastomosis vs. other anastomotic configurations after resection in Crohn’s disease. Dis Colon Rectum 2007; 50: 1674-1687
    CrossrefPubMedGoogle Scholar
  • 36 Smedh K, Andersson M, Johansson H et al. Preoperative management is more important than choice of sutured or stapled anastomosis in Crohn’s disease. Eur J Surg 2002; 168: 154-157
    CrossrefPubMedGoogle Scholar
  • 37 McLeod RS, Wolff BG, Ross S et al. Investigators of the CAST Trial. Recurrence of Crohn’s disease after ileocolic resection is not affected by anastomotic type: results of a multicenter, randomized, controlled trial. Dis Colon Rectum 2009; 52: 919-927
    CrossrefPubMedGoogle Scholar
  • 38 Jeejeebhoy KN, Detsky AS, Baker JP. Assessment of nutritional status. JPEN J Parenter Enteral Nutr 1990; 14: 193S-196S
    CrossrefPubMedGoogle Scholar
  • 39 Weimann A, Braga M, Harsanyi L et al. ESPEN Guidelines on Enteral Nutrition: Surgery including organ transplantation. Clin Nutr 2006; 25: 224-244
    CrossrefPubMedGoogle Scholar
  • 40 Müller-Wille R, Iesalnieks I, Dornia C et al. Influence of percutaneous abscess drainage on severe postoperative septic complications in patients with Crohn’s disease. Int J Colorectal Dis 2011; 26: 769-774
    CrossrefPubMedGoogle Scholar
  • 41 Goyer P, Alves A, Bretagnol F et al. Impact of complex Crohn’s disease on the outcome of laparoscopic ileocecal resection: a comparative clinical study in 124 patients. Dis Colon Rectum 2009; 52: 205-210
    CrossrefPubMedGoogle Scholar
  • 42 Iesalnieks I, Kilger A, Kalisch B et al. Treatment of the anastomotic complications in patients with Crohn’s disease. Int J Colorectal Dis 2011; 26: 239-244
    CrossrefPubMedGoogle Scholar
  • 43 Myrelid P, Söderholm JD, Olaison G et al. Split stoma in resectional surgery of high risk patients with ileocolonic Crohn’s disease. Colorectal Dis 2012; 14: 188-193
    CrossrefPubMedGoogle Scholar
  • 44 Longo WE, Oakley JR, Lavery IC et al. Outcome of ileorectal anastomosis for Crohn’s colitis. Dis Colon Rectum 1992; 35: 1066-1071
    CrossrefPubMedGoogle Scholar
  • 45 Fichera A, McCormack R, Rubin MA et al. Long-term outcome of surgically treated Crohn’s colitis: a prospective study. Dis Colon Rectum 2005; 48: 963-969
    CrossrefPubMedGoogle Scholar
  • 46 Iesalnieks I, Glaß H, Kilger A et al. Perianale Crohn-Fisteln – Ergebnisse der Behandlung in einer interdisziplinären Sprechstunde. Chirurg 2009; 80: 549-558
    CrossrefPubMedGoogle Scholar
  • 47 Iesalnieks I, Gaertner WB, Glass H et al. Fistula-associated anal adenocarcinoma in Crohn’s disease. Inflamm Bowel Dis 2010; 16: 1643-1648
    CrossrefPubMedGoogle Scholar
  • 48 Sjödahl RI, Myrelid P, Söderholm JD. Anal and rectal cancer in Crohn’s disease. Colorectal Dis 2003; 5: 490-495
    CrossrefPubMedGoogle Scholar
  • 49 Amiot A, Gornet JM, Baudry C et al. Crohn’s disease recurrence after total proctocolectomy with definitive ileostomy. Dig Liver Dis 2011; 43: 698-702
    CrossrefPubMedGoogle Scholar
  • 50 Aydin HN, Remzi FH, Tekkis PP et al. Hartmann’s reversal is associated with high postoperative adverse events. Dis Colon Rectum 2005; 48: 2117-2126
    CrossrefPubMedGoogle Scholar
  • 51 Holzheimer RG, Molloy RG, Wittmann DH. Postoperative complications predict recurrence of Crohn’s disease. Eur J Surg 1995; 161: 129-135
    PubMedGoogle Scholar
  • 52 Khoury W, Strong SA, Fazio VW et al. Factors associated with operative recurrence early after resection for Crohn’s disease. J Gastrointest Surg 2011; 15: 1354-1360
    CrossrefPubMedGoogle Scholar
  • 53 Iesalnieks I, Schlitt HJ, Agha A. Frühzeitiges Erkennen der postoperativen Komplikationen bei Patienten mit M. Crohn. 178. Jahrestagung der Vereinigung Niederrheinisch-Westfälischer Chirurgen. 20. und 21. Oktober 2011 Bochum: Abstract.
    PubMedGoogle Scholar
  • 54 Kørner H, Nielsen HJ, Søreide JA et al. Diagnostic accuracy of C-reactive protein for intraabdominal infections after colorectal resections. J Gastrointest Surg 2009; 13: 1599-1606
    CrossrefPubMedGoogle Scholar
  • 55 Matthiessen P, Henriksson M, Hallböök O et al. Increase of serum C-reactive protein is an early indicator of subsequent symptomatic anastomotic leakage after anterior resection. Colorectal Dis 2008; 10: 75-80
    PubMedGoogle Scholar